Developing high-concentration monoclonal antibody formulations for subcutaneous administration to improve patient treatment.

Biophys Rev · 2025 · PMC12686231 · PMID 41378112

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a notable trendno p-value reported

A notable trend emerges when comparing administered doses in immunology and oncology.

also in 2,155 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.